Inflammatory Breast Cancer - CMEZ174

Inflammatory Breast Cancer

Rare and Aggressive

by Steven S. Bhimji, MD, PhD
CMEZ174
(4.6 / 100 ratings )

This course is credentialed for:
Medicine (1.00 Credits)
Physician (1.00 Credits)

ONLINE
Price: $15.00
CE-PRO Price: $7.50

Summary:

Inflammatory breast cancer is not a common type of breast cancer. Overall, it accounts for about 2% to 5% of all cases of breast cancer. Inflammatory breast cancer develops and progresses rapidly, which accounts for a poor prognosis. The median survival for patients with inflammatory breast cancer is 15 months, even with treatment. It presents with signs and symptoms of inflammation, and is often mistaken for cellulitis. Physical exam may reveal a warm, indurated and erythematous breast, without an underlying mass, but axillary adenopathy is common. Also, it may present as a reddened breast, without systemic features of inflammation. Prompt biopsy followed by treatment by an interprofessional team is highly recommended. Unlike other breast cancers, initial treatment of inflammatory breast cancer is chemotherapy, followed by surgery and radiation.

Objectives:

The goal of this inflammatory breast cancer continuing education program is to provide pharmacists, physicians and imaging technologists with information about inflammatory breast cancer, its pathophysiology, presentation and treatment. After studying the information presented here, you will be able to:
  • Describe the pathology, presentation and examination of patients with inflammatory breast cancer
  • Discuss the role of chemotherapy, surgery and radiation in patients with primary inflammatory breast cancer, including management of adverse effects
  • List the novel types of treatment for patients with advanced inflammatory breast cancer
  • Discuss the types of cancer drugs used to treat inflammatory breast cancer
  • List other non-drug therapies for treatment of inflammatory breast cancer
 

 
Approval Information
 
This course is intended for an interprofessional audience, including pharmacists, physicians and imaging technologists.
 
Physicians: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com/ and search for this topic title.
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Medicine, Florida Board of Osteopathic Medicine, and Florida Physician Assistants (provider # FBN 50-1489).
 
Physician Continuing Education Credit
 
OnCourse Learning designates this enduring activity for a maximum of 1.0 AMA PRA category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Physician Assistant Continuing Education Credit
 
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category I credit for completing this program.
 
Disclosures
 
There is no commercial support provided for this online educational activity.

Course Originally Released on: 11/13/2014
Date of Most Recent Review: 11/13/2014
Course Termination/Update Date: 3/3/2018

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

 

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Rebecca P - Palm Springs, CA  ·  Sep 15, 2019
This is new information for me. Found this not only interesting but informative.
Was this review helpful?  0
 
Sharon M - Decatur, GA  ·  Aug 20, 2019
Very informative. Learned to improve diagnosing
Was this review helpful?  0
 
Jolanta B - Dunedin, FL  ·  Jul 16, 2019
I work with breast cancer patients but was interested in learning more. Especially pharmokinetics of chemotherapy
Was this review helpful?  0
 
Sara G - Rockville, MD  ·  Jul 11, 2019
excellent, informative and concise information.
Was this review helpful?  0
 
RUTH H - Beaumont, TX  ·  May 31, 2019
Very straight and to the point. Easy to understand and informative.
Was this review helpful?  0
 
  Page: of 7  
ONLINE
Price: $15.00
CE-PRO Price: $7.50